Mediar Therapeutics
Developer of innovative fibrosis treatment intended for halting and reversing fibrotic activity. The company utilizes antibodies to neutralize mediators that contribute to the development of chronical...
Valuation
$230M
Market implied
Share Price
N/A
Total Raised
$180.3M
Last Round
N/A
21 investors — free account required
Sign up free Investors
+21 other investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details